-
-based approach with antibody-based therapy in human B-NHL cell lines, primary DLBCL and CLL patient samples and lymphoma mouse models. This research will provide molecular and biological insight
-
-based approach with antibody-based therapy in human B-NHL cell lines, primary DLBCL and CLL patient samples and lymphoma mouse models. This research will provide molecular and biological insight
-
, or dosimetry. Further you recognize yourself in the profile below: Masters degree in (bio)physics, health physics, technical medicine, clinical technology, or equivalent. Experience with Geant4 or other relevant
-
, which had its official start date on 1st of January 2024. The primary objective of this EU-project is to develop a federated platform tailored to delve into the mechanisms underpinning the gut-brain axis
-
for patients and society? This is the job for you! As a postdoctoral researcher you will work closely with our team of researchers to conduct early HTAs. The primary focus will be on evaluating a new promising